HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunostimulant activity of n-butanol fraction of root bark of Oroxylum indicum, vent.

Abstract
In the present study, the immunomodulatory activity and the mechanism of action of the n-butanol fraction (100 mg/kg body weight, per os, once daily for 22 consecutive days) of the root bark of Oroxylum indicum, vent. (Bignoniaceae) was evaluated in rats using measures of immune responses to sheep red blood cells (SRBC haemagglutinating antibody [HA] titer) and delayed-type hypersensitivity (DTH) reactions. In response to SRBC, treatment with the n-butanol fraction caused a significant rise in circulating HA titers during secondary antibody responses, indicating a potentiation of certain aspects of the humoral response. The treatment also resulted in a significant rise in paw edema formation, indicating increased host DTH response. Additionally, the antioxidant potential of the drug was exhibited by significant reductions in whole blood malondialdehyde (MDA) content along with a rise in the activities/levels of superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH). Furthermore, histopathologic analysis of lymphoid tissues showed an increase in cellularity, e.g., T-lymphocytes and sinusoids, in the treatment group. In contrast, dexamethasone treatment caused significant reduction in the HA titer, DTH responses, and antioxidant potential. In a triple antigen-mediated immunological edema model, the extent of edema raised in drug-treated rats was greater compared to that in control rats, thus confirming enhanced DTH reactions in response to the drug treatment. Based on the above findings, the reported immunomodulatory activity of an active fraction of O. indicum might be attributed to its ability to enhance specific immune responses (both humoral and cell-mediated) as well as its antioxidant potential.
AuthorsMaitreyi Zaveri, Priyanshee Gohil, Sunita Jain
JournalJournal of immunotoxicology (J Immunotoxicol) Vol. 3 Issue 2 Pg. 83-99 (Jul 01 2006) ISSN: 1547-6901 [Electronic] England
PMID18958688 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: